Harry Bartelink combines Internal medicine and Gastroenterology in his studies. Gastroenterology and Internal medicine are two areas of study in which Harry Bartelink engages in interdisciplinary work. Surgery is closely attributed to Head and neck in his research. He connects Cancer with Lymph node in his research. Harry Bartelink merges Radiation therapy with Chemotherapy in his research. Harry Bartelink brings together Chemotherapy and Cancer to produce work in his papers. While working in this field, Harry Bartelink studies both Breast cancer and Mastectomy. His multidisciplinary approach integrates Mastectomy and Breast cancer in his work. Harry Bartelink merges Multivariate analysis with Univariate analysis in his study.
His Internal medicine study frequently links to other fields, such as Randomized controlled trial. His study deals with a combination of Randomized controlled trial and Cancer. Harry Bartelink carries out multidisciplinary research, doing studies in Cancer and Clinical trial. In his research, Harry Bartelink undertakes multidisciplinary study on Surgery and Radiology. By researching both Radiology and Internal medicine, he produces research that crosses academic boundaries. Harry Bartelink combines Oncology and Chemotherapy in his research. Harry Bartelink performs integrative study on Chemotherapy and Cisplatin in his works. He brings together Breast cancer and Mastectomy to produce work in his papers. Harry Bartelink conducted interdisciplinary study in his works that combined Mastectomy and Breast cancer.
His work on Internal medicine is being expanded to include thematically relevant topics such as Proportional hazards model. In his works, he undertakes multidisciplinary study on Cancer and Clinical endpoint. Breast cancer and Systemic therapy are commonly linked in his work. While working in this field, Harry Bartelink studies both Oncology and Gynecology. Harry Bartelink undertakes multidisciplinary investigations into Gynecology and Oncology in his work. His study deals with a combination of Paleontology and Stage (stratigraphy). He performs multidisciplinary studies into Stage (stratigraphy) and Paleontology in his work. Harry Bartelink integrates many fields in his works, including Mastectomy and Breast-conserving surgery. He carries out multidisciplinary research, doing studies in Breast-conserving surgery and Mastectomy.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Cohort. His Cohort study often links to related topics such as Internal medicine. Harry Bartelink connects Cancer with Ductal carcinoma in his study. His study deals with a combination of Ductal carcinoma and Cancer. In his articles, he combines various disciplines, including Mastectomy and Breast-conserving surgery. Harry Bartelink integrates Breast-conserving surgery with Mastectomy in his study. Many of his studies involve connections with topics such as Thoracic wall and Surgery. Harry Bartelink regularly ties together related areas like Surgery in his Thoracic wall studies. His Breast cancer study frequently draws connections to other fields, such as Supraclavicular lymph nodes.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai.
The New England Journal of Medicine (2002)
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
H Bartelink;F Roelofsen;F Eschwege;P Rougier.
Journal of Clinical Oncology (1997)
Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial
Joop A. van Dongen;Adri C. Voogd;Ian S. Fentiman;Catherine Legrand.
Journal of the National Cancer Institute (2000)
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans.
Journal of Clinical Oncology (2007)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
Howard Y. Chang;Dimitry S. A. Nuyten;Julie B. Sneddon;Trevor Hastie.
Proceedings of the National Academy of Sciences of the United States of America (2005)
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans.
The New England Journal of Medicine (2001)
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
Berthe M.P. Aleman;Alexandra W. van den Belt-Dusebout;Willem J. Klokman;Mars B. van’t Veer.
Journal of Clinical Oncology (2003)
Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
Maartje J. Hooning;Akke Botma;Berthe M. P. Aleman;Margreet H. A. Baaijens.
Journal of the National Cancer Institute (2007)
Internal mammary and medial supraclavicular irradiation in breast cancer
P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen.
The New England Journal of Medicine (2015)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Bas Kreike;Marieke van Kouwenhove;Hugo M Horlings;Britta Weigelt.
Breast Cancer Research (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: